HR. 6485In Committee
Skinny Labels, Big Savings Act
Establishes a patent infringement safe harbor for generic and biosimilar drug makers using FDA-approved skinny labels for unpatented uses
Plain-English overview
What this bill does
Establishes a patent infringement safe harbor for generic and biosimilar drug makers using FDA-approved skinny labels for unpatented uses
Key points
- Establish patent safe harbor
- Authorize skinny label approval actions
- Allow marketing of skinny label drugs
Current status
Where it stands
Status
In Committee
Latest action
2025-12-05 — Referred to the House Committee on the Judiciary.
Related context
Topics and policy areas
undefinedCommerce